Zhongzheng Xiang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma (NCT06199271) | Zhongzheng Xiang | 2024-01-31 |
Track Zhongzheng Xiang automatically
Every clearance here is in the API, with alerts when new ones post.